ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

A.D. Little Gets 42.4 Million Contract Award

May 2, 1975

ASCO Annual Meeting Abstracts Posted Online

May 28, 2010

MD Anderson Expands Reach Into Florida, Ohio

September 26, 2014

In Brief: House Appropriations Bill Marked Up, Lid Clamped On; Wells Named DCT Board Chairman

July 6, 1984

Physicians Group Makes No “Simple Recommendation” on Mammograms for Women Aged 40-49.

April 6, 2007